These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 556794)
41. Studies of tryptamine and lysergic acid diethylamide (LSD) on cutaneous C-fiber and polysynaptic reflexes in the cat. Bell JA; Martin WR J Pharmacol Exp Ther; 1974 Sep; 190(3):492-500. PubMed ID: 4607113 [No Abstract] [Full Text] [Related]
42. Lysergic acid diethylamide, chlorpromazine and maze performance. Uyeno ET Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):389-94. PubMed ID: 5453237 [No Abstract] [Full Text] [Related]
43. Serotonin-sensitive adenylate cyclase activity of immature rat brain. von Hungen K; Roberts S; Hill DF Brain Res; 1975 Feb; 84(2):257-67. PubMed ID: 1078637 [TBL] [Abstract][Full Text] [Related]
44. Some clinical and social aspects of lysergic acid diethylamide. I. Sarwer-Foner GJ Psychosomatics; 1972; 13(3):165-9 contd. PubMed ID: 4605125 [No Abstract] [Full Text] [Related]
45. Behavioural effects of some derivatives of amphetamine and LSD and their significance. Smythies JR; Beaton J; Benington F; Morin RD Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927 [No Abstract] [Full Text] [Related]
46. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature. Dyer DC J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552 [No Abstract] [Full Text] [Related]
48. Effects of LSD on open field performance in rats. Dandiya PC; Gupta BD; Gupta ML; Patni SK Psychopharmacologia; 1969; 15(4):333-40. PubMed ID: 5352145 [No Abstract] [Full Text] [Related]
50. 5-HT antagonists in rat hippocampus. Segal M Brain Res; 1976 Feb; 103(1):161-6. PubMed ID: 3262 [No Abstract] [Full Text] [Related]
51. Gross behavioural changes in monkeys following administration of LSD-25, and development of tolerance to LSD-25. Jonas S; Downer Jde C Psychopharmacologia; 1964 Oct; 6(4):303-6. PubMed ID: 4953438 [No Abstract] [Full Text] [Related]
52. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component. Winter JC J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911 [No Abstract] [Full Text] [Related]
53. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats]. Loew DM; Depoortere H; Vigouret JM Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420 [No Abstract] [Full Text] [Related]
54. On the specificity of a cat behavior model for the study of hallucinogens. Marini JL; Sheard MH Eur J Pharmacol; 1981 Apr; 70(4):479-87. PubMed ID: 7238573 [TBL] [Abstract][Full Text] [Related]
55. Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine. Horita A; Hamilton AE Science; 1969 Apr; 164(3875):78-9. PubMed ID: 5773714 [TBL] [Abstract][Full Text] [Related]
56. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance? Ellison G; Ring M; Ross D; Axelrood B Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060 [TBL] [Abstract][Full Text] [Related]